Inflammatory Myopathies in Primary Sjögren's Syndrome

Characterization of Inflammatory Muscle Involvement in Patients With Primary Sjögren's Syndrome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03126383

Acronym

AMISS

Enrollment

Registered

2017-04-24

Start date

2017-03-16

Completion date

2018-12-31

Last updated

2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Sjögren Syndrome

Brief summary

The AMISS study will characterize the features of muscle disease in patients with primary Sjogren's syndrome (pSS).

Detailed description

Muscle disease is associated with pSS, but this association is not well defined. The AMISS study, a retrospective observational multicentric study, will recruit patients with pSS and muscle involvement in order to characterize in details the features of this association (epidemiological aspects, clinical presentation, biological, radiological and histological findings, treatments and outcomes).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* diagnosis of Primary Sjögren's syndrome according to the ACR/EULAR classification criteria * inflammatory muscle involvement, as diagnosed by the treating physician

Exclusion criteria

* Diagnosis of inflammatory myopathy before the diagnosis of pSS

Design outcomes

Primary

Measure	Time frame	Description
Proportion of patients fulfilling classification criteria for inflammatory myopathies	At diagnosis	Among the patients included in the AMISS study, we will assess the proportion of patients who fulfill the classification criteria for the different inflammatory myopathies.

Countries

France

Outcome results